![Debbie W. Lin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Debbie W. Lin
Private Equity Investor bei
Boehringer Ingelheim (Venture Capital)
Profil
Debbie W.
Lin is currently working as an Executive Director at Boehringer Ingelheim (Venture Capital) since 2018.
Prior to this, she worked as a Director at Bodyport, Inc.
Aktive Positionen von Debbie W. Lin
| Unternehmen | Position | Beginn |
|---|---|---|
Boehringer Ingelheim (Venture Capital)
 Boehringer Ingelheim (Venture Capital) Investment ManagersFinance BIVF invests in companies located across the globe including the United States, Europe and China. The firm focuses on companies operating in groundbreaking innovation including cancer, auto-immunity indications, digital solutions, infectious disease and regenerative medicine services. It provides financing for seed and early stage capital requirements. The firm acquires minority interest and makes follow-on investments. It also takes board seat. | Private Equity Investor | 01.05.2018 |
Ehemalige bekannte Positionen von Debbie W. Lin
| Unternehmen | Position | Ende |
|---|---|---|
Bodyport, Inc.
 Bodyport, Inc. Packaged SoftwareTechnology Services Publishes mobile applications which provides blood pressure, heart rate and other health information | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
30
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Boehringer Ingelheim (Venture Capital)
Boehringer Ingelheim (Venture Capital) Investment ManagersFinance BIVF invests in companies located across the globe including the United States, Europe and China. The firm focuses on companies operating in groundbreaking innovation including cancer, auto-immunity indications, digital solutions, infectious disease and regenerative medicine services. It provides financing for seed and early stage capital requirements. The firm acquires minority interest and makes follow-on investments. It also takes board seat. | Finance |
Bodyport, Inc.
Bodyport, Inc. Packaged SoftwareTechnology Services Publishes mobile applications which provides blood pressure, heart rate and other health information | Technology Services |
